应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
LPTX Leap Therapeutics Inc
休市中 04-26 16:00:00 EDT
3.25
+0.08
+2.52%
盘后
3.11
-0.14
-4.31%
18:55 EDT
最高
3.39
最低
2.99
成交量
40.32万
今开
3.29
昨收
3.17
日振幅
12.62%
总市值
8,321万
流通市值
6,322万
总股本
2,560万
成交额
128.24万
换手率
2.07%
流通股本
1,945万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
美国研究综述-美国大厦、莱纳尔、耐克
Reuters · 03-19
美国研究综述-美国大厦、莱纳尔、耐克
Leap Therapeutics, Inc.盘中异动 早盘股价大跌5.02%
自选股智能写手 · 03-14
Leap Therapeutics, Inc.盘中异动 早盘股价大跌5.02%
暂无数据
公司概况
公司名称:
Leap Therapeutics Inc
所属市场:
NASDAQ
上市日期:
--
主营业务:
Leap Therapeutics, Inc.最初作为Dekkun Corporation成立于2011年1月3日,一家特拉华州公司。该公司是一家开发新型生物标志物靶向抗体疗法的生物制药公司,旨在通过抑制基本的肿瘤促进途径、靶向癌症特异性细胞表面分子和利用免疫系统攻击癌细胞来治疗癌症患者。他们的策略是识别、获取和开发分子,这些分子将迅速转化为高影响的治疗方法,产生持久的临床效益并提高患者的预后。他们的主要临床阶段项目是DKN-01,一种抑制dickkopf相关蛋白1(“DKK1”)的单克隆抗体。他们目前正在多个正在进行的临床试验中研究DKN-01在食管胃癌、妇科癌症或结直肠癌患者中的应用。他们的第二个临床阶段项目是FL-301,这是一种针对细胞表面表达Claudin18.2的细胞的单克隆抗体。他们还有两个临床前抗体项目,FL-302和FL-501。
发行价格:
--
{"stockData":{"symbol":"LPTX","market":"US","secType":"STK","nameCN":"Leap Therapeutics Inc","latestPrice":3.25,"timestamp":1714161600000,"preClose":3.17,"halted":0,"volume":403202,"hourTrading":{"tag":"盘后","latestPrice":3.11,"preClose":3.25,"latestTime":"18:55 EDT","volume":7833,"amount":24319.85,"timestamp":1714172117538},"delay":0,"floatShares":19452582,"shares":25603471,"eps":-3.982077,"marketStatus":"休市中","marketStatusCode":7,"change":0.08,"latestTime":"04-26 16:00:00 EDT","open":3.29,"high":3.39,"low":2.99,"amount":1282434.2402894,"amplitude":0.126183,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-3.982077,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1714377600000},"adr":0,"adjPreClose":3.17,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":3.26,"preClose":3.17,"latestTime":"09:12 EDT","volume":20,"amount":65.19999999999999,"timestamp":1714137178084},"postHourTrading":{"tag":"盘后","latestPrice":3.11,"preClose":3.25,"latestTime":"18:55 EDT","volume":7833,"amount":24319.85,"timestamp":1714172117538},"volumeRatio":1.9283012184981223},"requestUrl":"/m/hq/s/LPTX/tweets","defaultTab":"tweets","newsList":[{"id":"2420255290","title":"美国研究综述-美国大厦、莱纳尔、耐克","url":"https://stock-news.laohu8.com/highlight/detail?id=2420255290","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2420255290?lang=zh_cn&edition=full","pubTime":"2024-03-19 15:17","pubTimestamp":1710832652,"startTime":"0","endTime":"0","summary":" 路透社3月19日 - 华尔街证券分析师周二调整了对美国塔、莱纳尔和耐克等几家美国上市公司的评级和目标价。* 耐克公司 :Wedbush将目标价从131美元下调至115美元 * Zoom Video Communications :杰富瑞给予该公司 \"持有 \"评级,目标价为70美元 以下是路透社周二报道的美国公司研究行动摘要。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2419998860","title":"Leap Therapeutics, Inc.盘中异动 早盘股价大跌5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2419998860","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2419998860?lang=zh_cn&edition=full","pubTime":"2024-03-14 22:07","pubTimestamp":1710425260,"startTime":"0","endTime":"0","summary":"北京时间2024年03月14日22时07分,Leap Therapeutics, Inc.股票出现波动,股价急速下挫5.02%。Leap Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.59%。Leap Therapeutics, Inc.公司简介:Leap Therapeutics Inc 是一家生物制药公司,开发旨在通过抑制基本的肿瘤促进途径和利用免疫系统攻击癌细胞来治疗癌症患者的新型疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403142207407a4cb7b0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403142207407a4cb7b0&s=b","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.leaptx.com","stockEarnings":[{"period":"1week","weight":0.1607},{"period":"1month","weight":0.1691},{"period":"3month","weight":0.332},{"period":"6month","weight":1.3214},{"period":"1year","weight":-0.158},{"period":"ytd","weight":-0.2159}],"compareEarnings":[{"period":"1week","weight":0.0265},{"period":"1month","weight":-0.0285},{"period":"3month","weight":0.0428},{"period":"6month","weight":0.2376},{"period":"1year","weight":0.2324},{"period":"ytd","weight":0.0693}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Leap Therapeutics, Inc.最初作为Dekkun Corporation成立于2011年1月3日,一家特拉华州公司。该公司是一家开发新型生物标志物靶向抗体疗法的生物制药公司,旨在通过抑制基本的肿瘤促进途径、靶向癌症特异性细胞表面分子和利用免疫系统攻击癌细胞来治疗癌症患者。他们的策略是识别、获取和开发分子,这些分子将迅速转化为高影响的治疗方法,产生持久的临床效益并提高患者的预后。他们的主要临床阶段项目是DKN-01,一种抑制dickkopf相关蛋白1(“DKK1”)的单克隆抗体。他们目前正在多个正在进行的临床试验中研究DKN-01在食管胃癌、妇科癌症或结直肠癌患者中的应用。他们的第二个临床阶段项目是FL-301,这是一种针对细胞表面表达Claudin18.2的细胞的单克隆抗体。他们还有两个临床前抗体项目,FL-302和FL-501。","yearOnYearQuotes":[{"month":1,"riseRate":0.571429,"avgChangeRate":0.083819},{"month":2,"riseRate":0.375,"avgChangeRate":-0.003011},{"month":3,"riseRate":0.375,"avgChangeRate":-0.044957},{"month":4,"riseRate":0.375,"avgChangeRate":-0.012173},{"month":5,"riseRate":0.428571,"avgChangeRate":0.183652},{"month":6,"riseRate":0.428571,"avgChangeRate":-0.070445},{"month":7,"riseRate":0.142857,"avgChangeRate":-0.041716},{"month":8,"riseRate":0.285714,"avgChangeRate":-0.030488},{"month":9,"riseRate":0.428571,"avgChangeRate":0.074641},{"month":10,"riseRate":0.285714,"avgChangeRate":-0.096916},{"month":11,"riseRate":0.285714,"avgChangeRate":-0.06693},{"month":12,"riseRate":0.571429,"avgChangeRate":0.185169}],"exchange":"NASDAQ","name":"Leap Therapeutics Inc","nameEN":"Leap Therapeutics Inc"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Leap Therapeutics Inc(LPTX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Leap Therapeutics Inc(LPTX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Leap Therapeutics Inc,LPTX,Leap Therapeutics Inc股票,Leap Therapeutics Inc股票老虎,Leap Therapeutics Inc股票老虎国际,Leap Therapeutics Inc行情,Leap Therapeutics Inc股票行情,Leap Therapeutics Inc股价,Leap Therapeutics Inc股市,Leap Therapeutics Inc股票价格,Leap Therapeutics Inc股票交易,Leap Therapeutics Inc股票购买,Leap Therapeutics Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Leap Therapeutics Inc(LPTX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Leap Therapeutics Inc(LPTX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}